Conserved epitopes of HCV from NS4B, NS5A and NS3 have been predicted.
Three HLA - I & one HLA -II restricted epitopes have been selected for final vaccine cocktail and population coverage.
75.53% and 70.77% population coverage for Pakistani Asian and Mixed respectively have been estimated.